\
&
Contact us
\
&
Contact us
Published on | 1 day ago
Programmes Security Cybersecurity Defence SpaceThe Start2DEF programme, led by the Royal Higher Institute for Defence (RHID) in collaboration with imec.istart and Ignity, focuses on involving Belgian startups and small SMEs to address current Defence challenges while promoting technological innovation. Information about the call for proposals, including participation guidelines, is accessible on the official website at www.start2def.be starting October 1.
Interested companies may submit proof-of-concept proposals related to one of these themes:
To provide further details about the programme, an online information session is scheduled for October 10, 2025. This session will outline the programme guidelines and address any participant questions.
Visit www.start2def.be for detailed information on the call for proposals and guidelines. Attend the online information session on October 10, 2025, to learn more.
We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).
Stay informed about what matters to you.
By signing up, you can opt in for e-mail notifications and get access to
a personalised dashboard that groups all news updates and event announcements in your domain(s).
Only for stakeholders located in Flanders
The Horizon2020 project BEAT-AF brings together 9 European renowned clinical centres in France, Belgium, Czechia, Germany and Austria. Together, the consortium strives to revolutionize Atrial Fibrillation (AF) treatment through catheter ablation and contribute to decrease the huge burden of AF in Europe. The BEAT-AF project kicked off in 2021 and will run until 2026. The department of electrophysiology of the AZ Sint-Jan Hospital in Bruges is partner in the project and has so far contributed to the pre-clinical development, the first in man studies and first registries of the revolutionary AF treatment put forward by the consortium. The first pilot studies show that the treatment is safe, effective and efficient.
